Skip to main content
Clinical Trials/CTRI/2019/07/020067
CTRI/2019/07/020067
Active, not recruiting
Phase 4

A Cross-sectional, Multicenter, Epidemiological Study to Determine the Sociodemographic and Clinical Profiles of Patients With Irritable Bowel Syndrome (IBS) in India

Abbott Healthcare India Pvt Ltd0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: K589- Irritable bowel syndrome without diarrhea
Sponsor
Abbott Healthcare India Pvt Ltd
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Abbott Healthcare India Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • 1\.Male or female patients aged \>\= 18 years
  • 2\. Patients diagnosed with IBS in last 1 month as per the Asian criteria
  • 3\. Patients who are willing to participate in the study and competent to sign a patient authorization form (PAF) for participation in the registry

Exclusion Criteria

  • 1\. IBS patients with evidence of structural abnormality in the GI tract or diseases/conditions that may affect bowel transit
  • 2\. IBS patients with evidence of acute GI conditions like obstructions, bleeding, and perforation, or GI surgery
  • 3\. IBS patients with evidence of severe systemic disorders (cardiac, hepatic, neurological, or renal)
  • 4\. Pregnant or lactating patients
  • 5\. Any condition that in the opinion of the investigator does not justify the patientâ??s inclusion in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials